About Index Trending news
Analyze
Pricing
Seres Therapeutics

Seres Therapeutics

Seres Therapeutics

SERES HEALTH designs and develops products that will improve the dignity for patients with stomas & ostomies

Elsewhere

Contributors to this profile

Alexa global traffic share

Twitter followers

Latest funding Show all
IPO
$134,000,000
Venture capital (Series D)
$65,000,000
Nestlé Health Science
Employees

Team size

10+
Locations
HQ
$134,000,000 IPO
Xconomy

Bon Appetit: Seres And Its Microbiome Gut Treatment Notch $134M IPO

Health
$65,000,000 Venture capital (Series D)
prnewswire

Seres Health Announces $65 Million Investment from Nestle Health Science